A comparison between abacavir and efavirenz as the third drug used in combination with a background therapy regimen of 2 nucleoside reverse-transcriptase inhibitors in patients with initially suppressed viral loads.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples